
Arthroplasty
Enoxaparin does not significantly reduce rates of deep vein thrombosis after TKA
J Arthroplasty. 2006 Sep;21(6 Suppl 2):139-43.275 patients undergoing unilateral total knee arthroplasty were randomized to receive spinal epidural anaesthesia, VenaFlow compression device, and enoxaparin or spinal epidural anaesthesia, VenaFlow compression device, and aspirin to prevent deep vein thrombosis. Enoxaparin and aspirin were taken for 4 weeks after surgery. Deep vein thrombosis was diagnosed through ultrasonography completed 3 to 5 days and 4 to 6 weeks after surgery. At the end of the 6 week study period, it was found that the rates of deep thrombosis experienced by the enoxaparin group (14.1%) and the aspirin group (17.8%) were not significantly different.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.